(Q54408361)

29 May 2018

title

Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. (English)

1 reference

29 May 2018

0 references

1 reference

Elizabeth K Nugent

1

1 reference

29 May 2018

Ashley S Case

2

1 reference

29 May 2018

John T Hoff

3

1 reference

29 May 2018

Israel Zighelboim

4

1 reference

29 May 2018

Lorri L DeWitt

5

1 reference

29 May 2018

Kim Trinkhaus

6

1 reference

29 May 2018

David G Mutch

7

1 reference

29 May 2018

Premal H Thaker

8

1 reference

29 May 2018

L Stewart Massad

9

1 reference

29 May 2018

Janet S Rader

10

1 reference

29 May 2018

language of work or name

English

0 references

publication date

5 November 2009

1 reference

29 May 2018

published in

Gynecologic Oncology

1 reference

29 May 2018

volume

116

1 reference

29 May 2018

issue

3

1 reference

29 May 2018

page(s)

438-441

1 reference

29 May 2018

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

Prognostic importance of comorbidity in a hospital-based cancer registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.09.045

10.1016/J.YGYNO.2009.09.045

7 January 2021

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018